{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:45:14Z","timestamp":1793321114541,"version":"4.5.0"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12974-015-0358-9","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T20:27:19Z","timestamp":1442435239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["\u2018Medusa head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo\/CDR2, anti-Nb\/AP3B2, PCA-2, anti-Tr\/DNER, other antibodies, diagnostic pitfalls, summary and outlook"],"prefix":"10.1186","volume":"12","author":[{"given":"S.","family":"Jarius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Wildemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,17]]},"reference":[{"key":"358_CR1","doi-asserted-by":"crossref","unstructured":"Jarius S, Wildemann B. \u2018Medusa head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj\/ITPR1 and anti-CARP VIII. J Neuroinflammation. 2015, 12:166.","DOI":"10.1186\/s12974-015-0356-y"},{"key":"358_CR2","doi-asserted-by":"crossref","unstructured":"Jarius S, Wildemann B. \u2018Medusa head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca\/ARHGAP26 and anti-VGCC. J Neuroinflammation. 2015, 12:167.","DOI":"10.1186\/s12974-015-0357-x"},{"key":"358_CR3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ana.410140603","volume":"14","author":"JE Greenlee","year":"1983","unstructured":"Greenlee JE, Brashear HR. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol. 1983;14:609\u201313.","journal-title":"Ann Neurol"},{"key":"358_CR4","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/WNL.42.10.1931","volume":"42","author":"K Peterson","year":"1992","unstructured":"Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology. 1992;42:1931\u20137.","journal-title":"Neurology"},{"key":"358_CR5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/1531-8249(20010201)49:2<253::AID-ANA47>3.0.CO;2-3","volume":"49","author":"IJ Sutton","year":"2001","unstructured":"Sutton IJ, Fursdon Davis CJ, Esiri MM, Hughes S, Amyes ER, Vincent A. Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus. Ann Neurol. 2001;49:253\u20137.","journal-title":"Ann Neurol"},{"key":"358_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-510X(01)00467-1","volume":"185","author":"B Meglic","year":"2001","unstructured":"Meglic B, Graus F, Grad A. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma. J Neurol Sci. 2001;185:135\u20138.","journal-title":"J Neurol Sci"},{"key":"358_CR7","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1212\/WNL.46.5.1486","volume":"46","author":"J Krakauer","year":"1996","unstructured":"Krakauer J, Balmaceda C, Gluck JT, Posner JB, Fetell MR, Dalmau J. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of unknown origin. Neurology. 1996;46:1486\u20137.","journal-title":"Neurology"},{"key":"358_CR8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/jnnp.2006.112961","volume":"78","author":"J Matschke","year":"2007","unstructured":"Matschke J, Kromminga A, Erbersdobler A, Lamszus K, Anders S, Kofuncu E. Paraneoplastic cerebellar degeneration and anti-Yo antibodies in a man with prostatic adenocarcinoma. J Neurol Neurosurg Psychiatry. 2007;78:775\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"358_CR9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000107782","volume":"24","author":"JD Debes","year":"2007","unstructured":"Debes JD, Lagarde SM, Hulsenboom E, Sillevis Smitt PA, ten Kate FJ, Sulter GA, et al. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction. Dig Surg. 2007;24:395\u20137.","journal-title":"Dig Surg"},{"key":"358_CR10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-5728(03)00257-1","volume":"141","author":"O Stich","year":"2003","unstructured":"Stich O, Graus F, Rasiah C, Rauer S. Qualitative evidence of anti-Yo-specific intrathecal antibody synthesis in patients with paraneoplastic cerebellar degeneration. J Neuroimmunol. 2003;141:165\u20139.","journal-title":"J Neuroimmunol"},{"key":"358_CR11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","volume":"18","author":"MJ Titulaer","year":"2011","unstructured":"Titulaer MJ, Soffietti R, Dalmau J, Gilhus NE, Giometto B, Graus F, et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol. 2011;18:19\u2013e13.","journal-title":"Eur J Neurol"},{"key":"358_CR12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4103\/0972-2327.138528","volume":"17","author":"A Bhargava","year":"2014","unstructured":"Bhargava A, Bhushan B, Kasundra GM, Shubhakaran K, Pujar GS, Banakar B. Response to abdominal hysterectomy with bilateral salpingo-oophorectomy in postmenopausal woman with anti-Yo antibody mediated paraneoplastic cerebellar degeneration. Ann Indian Acad Neurol. 2014;17:355\u20137.","journal-title":"Ann Indian Acad Neurol"},{"key":"358_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s004150050054","volume":"244","author":"M Drlicek","year":"1997","unstructured":"Drlicek M, Bianchi G, Bogliun G, Casati B, Grisold W, Kolig C, et al. Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients. J Neurol. 1997;244:85\u20139.","journal-title":"J Neurol"},{"key":"358_CR14","doi-asserted-by":"crossref","first-page":"e66002","DOI":"10.1371\/journal.pone.0066002","volume":"8","author":"TW Eichler","year":"2013","unstructured":"Eichler TW, Totland C, Haugen M, Qvale TH, Mazengia K, Storstein A, et al. CDR2L antibodies: a new player in paraneoplastic cerebellar degeneration. PLoS One. 2013;8:e66002.","journal-title":"PLoS One"},{"key":"358_CR15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1212\/WNL.55.5.713","volume":"55","author":"I Rojas","year":"2000","unstructured":"Rojas I, Graus F, Keime-Guibert F, Rene R, Delattre JY, Ramon JM, et al. Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology. 2000;55:713\u20135.","journal-title":"Neurology"},{"key":"358_CR16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jnnp.68.4.479","volume":"68","author":"F Keime-Guibert","year":"2000","unstructured":"Keime-Guibert F, Graus F, Fleury A, Rene R, Honnorat J, Broet P, et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry. 2000;68:479\u201382.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"358_CR17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11060-006-9198-x","volume":"81","author":"S Phuphanich","year":"2007","unstructured":"Phuphanich S, Brock C. Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody. J Neurooncol. 2007;81:67\u20139.","journal-title":"J Neurooncol"},{"key":"358_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1023\/A:1023931501503","volume":"63","author":"P Widdess-Walsh","year":"2003","unstructured":"Widdess-Walsh P, Tavee JO, Schuele S, Stevens GH. Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature. J Neurooncol. 2003;63:187\u201390.","journal-title":"J Neurooncol"},{"key":"358_CR19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jns.2008.04.020","volume":"272","author":"J Thone","year":"2008","unstructured":"Thone J, Hohaus A, Lamprecht S, Bickel A, Erbguth F. Effective immunosuppressant therapy with cyclophosphamide and corticosteroids in paraneoplastic cerebellar degeneration. J Neurol Sci. 2008;272:171\u20133.","journal-title":"J Neurol Sci"},{"key":"358_CR20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00415-005-0882-0","volume":"253","author":"S Shams\u2019ili","year":"2006","unstructured":"Shams\u2019ili S, de Beukelaar J, Gratama JW, Hooijkaas H, van den Bent M, van \u2018t Veer M, et al. An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. J Neurol. 2006;253:16\u201320.","journal-title":"J Neurol"},{"key":"358_CR21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ana.410280515","volume":"28","author":"K Sakai","year":"1990","unstructured":"Sakai K, Mitchell DJ, Tsukamoto T, Steinman L. Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. Ann Neurol. 1990;28:692\u20138.","journal-title":"Ann Neurol"},{"key":"358_CR22","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1073\/pnas.88.8.3451","volume":"88","author":"H Fathallah-Shaykh","year":"1991","unstructured":"Fathallah-Shaykh H, Wolf S, Wong E, Posner JB, Furneaux HM. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A. 1991;88:3451\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"358_CR23","first-page":"2136","volume":"60","author":"JC Darnell","year":"2000","unstructured":"Darnell JC, Albert ML, Darnell RB. CDR2, a target antigen of naturally occurring human tumor immunity, is widely expressed in gynecological tumors. Cancer Res. 2000;60:2136\u20139.","journal-title":"Cancer Res"},{"key":"358_CR24","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1523\/JNEUROSCI.17-04-01406.1997","volume":"17","author":"JP Corradi","year":"1997","unstructured":"Corradi JP, Yang C, Darnell JC, Dalmau J, Darnell RB. A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen CDR2 to immune privileged tissues. J Neurosci. 1997;17:1406\u201315.","journal-title":"J Neurosci"},{"key":"358_CR25","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJM199006283222604","volume":"322","author":"HM Furneaux","year":"1990","unstructured":"Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F, et al. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med. 1990;322:1844\u201351.","journal-title":"N Engl J Med"},{"key":"358_CR26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.410240142","volume":"24","author":"EJ Dropcho","year":"1988","unstructured":"Dropcho EJ, Furneaux H, Chen YT, Old LJ, Posner JB. Expression of the CDR brain protein by tumors from patients with paraneoplastic cerebellar degeneration. Ann Neurol. 1988;24:121\u20132.","journal-title":"Ann Neurol"},{"key":"358_CR27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/mcne.2001.1059","volume":"19","author":"K Sakai","year":"2002","unstructured":"Sakai K, Shirakawa T, Li Y, Kitagawa Y, Hirose G. Interaction of a paraneoplastic cerebellar degeneration-associated neuronal protein with the nuclear helix-loop-helix leucine zipper protein MRG X. Mol Cell Neurosci. 2002;19:477\u201384.","journal-title":"Mol Cell Neurosci"},{"key":"358_CR28","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1073\/pnas.84.13.4552","volume":"84","author":"EJ Dropcho","year":"1987","unstructured":"Dropcho EJ, Chen YT, Posner JB, Old LJ. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A. 1987;84:4552\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"358_CR29","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1073\/pnas.86.8.2873","volume":"86","author":"HM Furneaux","year":"1989","unstructured":"Furneaux HM, Dropcho EJ, Barbut D, Chen YT, Rosenblum MK, Old LJ, et al. Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A. 1989;86:2873\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"358_CR30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00262-010-0943-9","volume":"60","author":"C Totland","year":"2011","unstructured":"Totland C, Aarskog NK, Eichler TW, Haugen M, Nostbakken JK, Monstad SE, et al. CDR2 antigen and Yo antibodies. Cancer Immunol Immunother. 2011;60:283\u20139.","journal-title":"Cancer Immunol Immunother"},{"key":"358_CR31","volume-title":"Paraneoplastic syndromes","author":"RB Darnell","year":"2011","unstructured":"Darnell RB, Posner JB. Paraneoplastic syndromes. Oxford, New York: Oxford University Press; 2011."},{"key":"358_CR32","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00401-014-1351-6","volume":"128","author":"M Schubert","year":"2014","unstructured":"Schubert M, Panja D, Haugen M, Bramham CR, Vedeler CA. Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis. Acta Neuropathol. 2014;128:835\u201352.","journal-title":"Acta Neuropathol"},{"key":"358_CR33","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419.","journal-title":"Science"},{"key":"358_CR34","first-page":"412","volume":"65","author":"HJ Altermatt","year":"1991","unstructured":"Altermatt HJ, Rodriguez M, Scheithauer BW, Lennon VA. Paraneoplastic anti-Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells. Lab Invest. 1991;65:412\u201320.","journal-title":"Lab Invest"},{"key":"358_CR35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1531-8249(200003)47:3<297::AID-ANA4>3.0.CO;2-4","volume":"47","author":"S Vernino","year":"2000","unstructured":"Vernino S, Lennon VA. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity. Ann Neurol. 2000;47:297\u2013305.","journal-title":"Ann Neurol"},{"key":"358_CR36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-5728(96)00205-6","volume":"74","author":"F Graus","year":"1997","unstructured":"Graus F, Dalmau J, Valldeoriola F, Ferrer I, Rene R, Marin C, et al. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin\u2019s disease. J Neuroimmunol. 1997;74:55\u201361.","journal-title":"J Neuroimmunol"},{"key":"358_CR37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ana.410290621","volume":"29","author":"HJ Altermatt","year":"1991","unstructured":"Altermatt HJ, Williams CL, Lennon VA. Paraneoplastic cerebellar autoantibodies associated with gynecological cancer bind to myenteric plexus neurons. Ann Neurol. 1991;29:687\u20138.","journal-title":"Ann Neurol"},{"key":"358_CR38","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1212\/WNL.38.9.1380","volume":"38","author":"M Rodriguez","year":"1988","unstructured":"Rodriguez M, Truh LI, O\u2019Neill BP, Lennon VA. Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells. Neurology. 1988;38:1380\u20136.","journal-title":"Neurology"},{"key":"358_CR39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF00334892","volume":"86","author":"H Tomimoto","year":"1993","unstructured":"Tomimoto H, Brengman JM, Yanagihara T. Paraneoplastic cerebellar degeneration with a circulating antibody against neurons and non-neuronal cells. Acta Neuropathol. 1993;86:206\u201311.","journal-title":"Acta Neuropathol"},{"key":"358_CR40","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archneur.1994.00540180033010","volume":"51","author":"C Hida","year":"1994","unstructured":"Hida C, Tsukamoto T, Awano H, Yamamoto T. Ultrastructural localization of anti-Purkinje cell antibody-binding sites in paraneoplastic cerebellar degeneration. Arch Neurol. 1994;51:555\u20138.","journal-title":"Arch Neurol"},{"key":"358_CR41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2010.10.009","volume":"232","author":"A Storstein","year":"2011","unstructured":"Storstein A, Monstad SE, Haugen M, Mazengia K, Veltman D, Lohndal E, et al. Onconeural antibodies: improved detection and clinical correlations. J Neuroimmunol. 2011;232:166\u201370.","journal-title":"J Neuroimmunol"},{"key":"358_CR42","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jneuroim.2006.11.008","volume":"183","author":"O Stich","year":"2007","unstructured":"Stich O, Jarius S, Kleer B, Rasiah C, Voltz R, Rauer S. Specific antibody index in cerebrospinal fluid from patients with central and peripheral paraneoplastic neurological syndromes. J Neuroimmunol. 2007;183:220\u20134.","journal-title":"J Neuroimmunol"},{"key":"358_CR43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2005.04.024","volume":"165","author":"A Storstein","year":"2005","unstructured":"Storstein A, Knudsen A, Vedeler CA. Proteasome antibodies in paraneoplastic cerebellar degeneration. J Neuroimmunol. 2005;165:172\u20138.","journal-title":"J Neuroimmunol"},{"key":"358_CR44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00262-009-0742-3","volume":"59","author":"C Totland","year":"2010","unstructured":"Totland C, Bredholt G, Haugen M, Haukanes BI, Vedeler CA. Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo). Cancer Immunol Immunother. 2010;59:231\u20137.","journal-title":"Cancer Immunol Immunother"},{"key":"358_CR45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s004010050460","volume":"91","author":"J Verschuuren","year":"1996","unstructured":"Verschuuren J, Chuang L, Rosenblum MK, Lieberman F, Pryor A, Posner JB, et al. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol. 1996;91:519\u201325.","journal-title":"Acta Neuropathol"},{"key":"358_CR46","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0404.2008.01138.x","volume":"120","author":"A Storstein","year":"2009","unstructured":"Storstein A, Krossnes BK, Vedeler CA. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies. Acta Neurol Scand. 2009;120:64\u20137.","journal-title":"Acta Neurol Scand"},{"key":"358_CR47","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2990.1997.tb01323.x","volume":"23","author":"B Giometto","year":"1997","unstructured":"Giometto B, Marchiori GC, Nicolao P, Scaravilli T, Lion A, Bardin PG, et al. Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system. Neuropathol Appl Neurobiol. 1997;23:468\u201374.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"358_CR48","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2990.2007.00909.x","volume":"34","author":"F Aboul-Enein","year":"2008","unstructured":"Aboul-Enein F, Hoftberger R, Buxhofer-Ausch V, Drlicek M, Lassmann H, Budka H, et al. Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome. Neuropathol Appl Neurobiol. 2008;34:248\u201352.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"358_CR49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/1531-8249(200001)47:1<9::AID-ANA5>3.0.CO;2-I","volume":"47","author":"ML Albert","year":"2000","unstructured":"Albert ML, Austin LM, Darnell RB. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol. 2000;47:9\u201317.","journal-title":"Ann Neurol"},{"key":"358_CR50","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/01.WNL.0000041495.87539.98","volume":"60","author":"F Bernal","year":"2003","unstructured":"Bernal F, Shams\u2019ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, et al. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin\u2019s disease. Neurology. 2003;60:230\u20134.","journal-title":"Neurology"},{"key":"358_CR51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0165-5728(00)00445-8","volume":"114","author":"E Amyes","year":"2001","unstructured":"Amyes E, Curnow J, Stark Z, Corlett L, Sutton I, Vincent A. Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration. J Neuroimmunol. 2001;114:259\u201364.","journal-title":"J Neuroimmunol"},{"key":"358_CR52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0022-510X(01)00442-7","volume":"184","author":"JE Greenlee","year":"2001","unstructured":"Greenlee JE, Boyden JW, Pingree M, Brashear HR, Clawson SA, Keeney PM. Antibody types and IgG subclasses in paraneoplastic neurological syndromes. J Neurol Sci. 2001;184:131\u20137.","journal-title":"J Neurol Sci"},{"key":"358_CR53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-5728(88)90133-6","volume":"18","author":"JL Smith","year":"1988","unstructured":"Smith JL, Finley JC, Lennon VA. Autoantibodies in paraneoplastic cerebellar degeneration bind to cytoplasmic antigens of Purkinje cells in humans, rats and mice and are of multiple immunoglobulin classes. J Neuroimmunol. 1988;18:37\u201348.","journal-title":"J Neuroimmunol"},{"key":"358_CR54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0022-510X(91)90198-G","volume":"106","author":"F Graus","year":"1991","unstructured":"Graus F, Illa I, Agusti M, Ribalta T, Cruz-Sanchez F, Juarez C. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. J Neurol Sci. 1991;106:82\u20137.","journal-title":"J Neurol Sci"},{"key":"358_CR55","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00309627","volume":"89","author":"JE Greenlee","year":"1995","unstructured":"Greenlee JE, Burns JB, Rose JW, Jaeckle KA, Clawson S. Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption. Acta Neuropathol. 1995;89:341\u20135.","journal-title":"Acta Neuropathol"},{"key":"358_CR56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1742-2094-6-31","volume":"6","author":"KE Hill","year":"2009","unstructured":"Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee JE. Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. J Neuroinflammation. 2009;6:31.","journal-title":"J Neuroinflammation"},{"key":"358_CR57","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/NEN.0b013e3181f0c82b","volume":"69","author":"JE Greenlee","year":"2010","unstructured":"Greenlee JE, Clawson SA, Hill KE, Wood BL, Tsunoda I, Carlson NG. Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures. J Neuropathol Exp Neurol. 2010;69:997\u20131007.","journal-title":"J Neuropathol Exp Neurol"},{"key":"358_CR58","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0303-8467(95)00006-6","volume":"97","author":"K Tanaka","year":"1995","unstructured":"Tanaka K, Tanaka M, Igarashi S, Onodera O, Miyatake T, Tsuji S. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice. Clin Neurol Neurosurg. 1995;97:101\u20135.","journal-title":"Clin Neurol Neurosurg"},{"key":"358_CR59","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/archneur.1985.04060070084021","volume":"42","author":"LF Borges","year":"1985","unstructured":"Borges LF, Busis NA. Intraneuronal accumulation of myeloma proteins. Arch Neurol. 1985;42:690\u20134.","journal-title":"Arch Neurol"},{"key":"358_CR60","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1101\/gad.13.16.2087","volume":"13","author":"HJ Okano","year":"1999","unstructured":"Okano HJ, Park WY, Corradi JP, Darnell RB. The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. Genes Dev. 1999;13:2087\u201397.","journal-title":"Genes Dev"},{"key":"358_CR61","doi-asserted-by":"crossref","first-page":"e10045","DOI":"10.1371\/journal.pone.0010045","volume":"5","author":"KJ O\u2019Donovan","year":"2010","unstructured":"O\u2019Donovan KJ, Diedler J, Couture GC, Fak JJ, Darnell RB. The onconeural antigen cdr2 is a novel APC\/C target that acts in mitosis to regulate c-Myc target genes in mammalian tumor cells. PLoS One. 2010;5:e10045.","journal-title":"PLoS One"},{"key":"358_CR62","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-5728(01)00368-X","volume":"119","author":"K Sakai","year":"2001","unstructured":"Sakai K, Kitagawa Y, Li Y, Shirakawa T, Hirose G. Suppression of the transcriptional activity and DNA binding of nuclear factor-kappa B by a paraneoplastic cerebellar degeneration-associated antigen. J Neuroimmunol. 2001;119:10\u20135.","journal-title":"J Neuroimmunol"},{"key":"358_CR63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0022-510X(94)90067-1","volume":"127","author":"K Tanaka","year":"1994","unstructured":"Tanaka K, Tanaka M, Onodera O, Igarashi S, Miyatake T, Tsuji S. Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration. J Neurol Sci. 1994;127:153\u20138.","journal-title":"J Neurol Sci"},{"key":"358_CR64","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0303-8467(95)00005-5","volume":"97","author":"M Tanaka","year":"1995","unstructured":"Tanaka M, Tanaka K, Onodera O, Tsuji S. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss. Clin Neurol Neurosurg. 1995;97:95\u2013100.","journal-title":"Clin Neurol Neurosurg"},{"key":"358_CR65","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/jaut.2001.0553","volume":"17","author":"K Sakai","year":"2001","unstructured":"Sakai K, Shirakawa T, Kitagawa Y, Li Y, Hirose G. Induction of cytotoxic T lymphocytes specific for paraneoplastic cerebellar degeneration-associated antigen in vivo by DNA immunization. J Autoimmun. 2001;17:297\u2013302.","journal-title":"J Autoimmun"},{"key":"358_CR66","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11064-013-1204-z","volume":"39","author":"D Lv","year":"2014","unstructured":"Lv D, Shi Q, Liu J, Zhang A, Miao F, He Y, et al. The similar expression pattern of MHC class I molecules in human and mouse cerebellar cortex. Neurochem Res. 2014;39:180\u20136.","journal-title":"Neurochem Res"},{"key":"358_CR67","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/3315","volume":"4","author":"ML Albert","year":"1998","unstructured":"Albert ML, Darnell JC, Bender A, Francisco LM, Bhardwaj N, Darnell RB. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med. 1998;4:1321\u20134.","journal-title":"Nat Med"},{"key":"358_CR68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-510X(01)00548-2","volume":"188","author":"M Tanaka","year":"2001","unstructured":"Tanaka M, Tanaka K, Tsuji S, Kawata A, Kojima S, Kurokawa T, et al. Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degeneration. J Neurol Sci. 2001;188:61\u20135.","journal-title":"J Neurol Sci"},{"key":"358_CR69","doi-asserted-by":"crossref","first-page":"19073","DOI":"10.1073\/pnas.0704336104","volume":"104","author":"BD Santomasso","year":"2007","unstructured":"Santomasso BD, Roberts WK, Thomas A, Williams T, Blachere NE, Dudley ME, et al. A T-cell receptor associated with naturally occurring human tumor immunity. Proc Natl Acad Sci U S A. 2007;104:19073\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"358_CR70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jneuroim.2003.12.026","volume":"150","author":"IJ Sutton","year":"2004","unstructured":"Sutton IJ, Steele J, Savage CO, Winer JB, Young LS. An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies. J Neuroimmunol. 2004;150:98\u2013106.","journal-title":"J Neuroimmunol"},{"key":"358_CR71","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2008.03.002","volume":"196","author":"T Tani","year":"2008","unstructured":"Tani T, Tanaka K, Idezuka J, Nishizawa M. Regulatory T cells in paraneoplastic neurological syndromes. J Neuroimmunol. 2008;196:166\u20139.","journal-title":"J Neuroimmunol"},{"key":"358_CR72","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jneuroim.2007.10.014","volume":"193","author":"EL Carpenter","year":"2008","unstructured":"Carpenter EL, Vance BA, Klein RS, Voloschin A, Dalmau J, Vonderheide RH. Functional analysis of CD8+ T cell responses to the onconeural self protein CDR2 in patients with paraneoplastic cerebellar degeneration. J Neuroimmunol. 2008;193:173\u201382.","journal-title":"J Neuroimmunol"},{"issue":"Suppl","key":"358_CR73","first-page":"260","volume":"39","author":"RB Darnell","year":"1989","unstructured":"Darnell RB, Furneaux HM, Posner JB. Characterization of antigens bound by CSF and serum of a patient with cerebellar degeneration: co-expression in Purkinje cells and tumor lines of neuroectodermal origin. Neurology. 1989;39(Suppl):260.","journal-title":"Neurology"},{"key":"358_CR74","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1523\/JNEUROSCI.11-05-01224.1991","volume":"11","author":"RB Darnell","year":"1991","unstructured":"Darnell RB, Furneaux HM, Posner JB. Antiserum from a patient with cerebellar degeneration identifies a novel protein in Purkinje cells, cortical neurons, and neuroectodermal tumors. J Neurosci. 1991;11:1224\u201330.","journal-title":"J Neurosci"},{"key":"358_CR75","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0092-8674(95)90474-3","volume":"82","author":"LS Newman","year":"1995","unstructured":"Newman LS, Mckeever MO, Okano HJ, Darnell RB. Beta-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein. Cell. 1995;82:773\u201383.","journal-title":"Cell"},{"key":"358_CR76","doi-asserted-by":"crossref","first-page":"8034","DOI":"10.1523\/JNEUROSCI.21-20-08034.2001","volume":"21","author":"J Blumstein","year":"2001","unstructured":"Blumstein J, Faundez V, Nakatsu F, Saito T, Ohno H, Kelly RB. The neuronal form of adaptor protein-3 is required for synaptic vesicle formation from endosomes. J Neurosci. 2001;21:8034\u201342.","journal-title":"J Neurosci"},{"key":"358_CR77","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1083\/jcb.200405032","volume":"167","author":"F Nakatsu","year":"2004","unstructured":"Nakatsu F, Okada M, Mori F, Kumazawa N, Iwasa H, Zhu G, et al. Defective function of GABA-containing synaptic vesicles in mice lacking the AP-3B clathrin adaptor. J Cell Biol. 2004;167:293\u2013302.","journal-title":"J Cell Biol"},{"key":"358_CR78","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1091\/mbc.E04-10-0892","volume":"16","author":"E Seong","year":"2005","unstructured":"Seong E, Wainer BH, Hughes ED, Saunders TL, Burmeister M, Faundez V. Genetic analysis of the neuronal and ubiquitous AP-3 adaptor complexes reveals divergent functions in brain. Mol Biol Cell. 2005;16:128\u201340.","journal-title":"Mol Biol Cell"},{"key":"358_CR79","doi-asserted-by":"crossref","first-page":"10035","DOI":"10.1073\/pnas.0509844103","volume":"103","author":"CP Grabner","year":"2006","unstructured":"Grabner CP, Price SD, Lysakowski A, Cahill AL, Fox AP. Regulation of large dense-core vesicle volume and neurotransmitter content mediated by adaptor protein 3. Proc Natl Acad Sci U S A. 2006;103:10035\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"358_CR80","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2045-8118-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Eichhorn P, Wildemann B, Wick M. Usefulness of antibody index assessment in cerebrospinal fluid from patients negative for total-IgG oligoclonal bands. Fluids Barriers CNS. 2012;9:14.","journal-title":"Fluids Barriers CNS"},{"key":"358_CR81","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jneuroim.2010.07.019","volume":"229","author":"S Jarius","year":"2010","unstructured":"Jarius S, Stich O, Speck J, Rasiah C, Wildemann B, Meinck HM, et al. Qualitative and quantitative evidence of anti-glutamic acid decarboxylase-specific intrathecal antibody synthesis in patients with stiff person syndrome. J Neuroimmunol. 2010;229:219\u201324.","journal-title":"J Neuroimmunol"},{"key":"358_CR82","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jns.2007.11.002","volume":"268","author":"S Jarius","year":"2008","unstructured":"Jarius S, Stich O, Rasiah C, Voltz R, Rauer S. Qualitative evidence of Ri specific IgG-synthesis in the cerebrospinal fluid from patients with paraneoplastic neurological syndromes. J Neurol Sci. 2008;268:65\u20138.","journal-title":"J Neurol Sci"},{"key":"358_CR83","doi-asserted-by":"crossref","unstructured":"Stich O, Kluge J, Speck J, Rauer S. Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients. Acta Neurol Scand. 2015;131:381\u20138.","DOI":"10.1111\/ane.12350"},{"key":"358_CR84","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1468-1331.2007.01802.x","volume":"14","author":"O Stich","year":"2007","unstructured":"Stich O, Rauer S. Antigen-specific oligoclonal bands in cerebrospinal fluid and serum from patients with anti-amphiphysin- and anti-CV2\/CRMP5 associated paraneoplastic neurological syndromes. Eur J Neurol. 2007;14:650\u20133.","journal-title":"Eur J Neurol"},{"key":"358_CR85","doi-asserted-by":"crossref","first-page":"10146","DOI":"10.1073\/pnas.95.17.10146","volume":"95","author":"DS Lim","year":"1998","unstructured":"Lim DS, Kirsch DG, Canman CE, Ahn JH, Ziv Y, Newman LS, et al. ATM binds to beta-adaptin in cytoplasmic vesicles. Proc Natl Acad Sci U S A. 1998;95:10146\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"358_CR86","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/geno.1997.4925","volume":"45","author":"CF Fletcher","year":"1997","unstructured":"Fletcher CF, Okano HJ, Gilbert DJ, Yang Y, Yang C, Copeland NG, et al. Mouse chromosomal locations of nine genes encoding homologs of human paraneoplastic neurologic disorder antigens. Genomics. 1997;45:313\u20139.","journal-title":"Genomics"},{"key":"358_CR87","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.23550","volume":"71","author":"E Graaff de","year":"2012","unstructured":"de Graaff E, Maat P, Hulsenboom E, van den Berg R, van den Bent M, Demmers J, et al. Identification of delta\/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. Ann Neurol. 2012;71:815\u201324.","journal-title":"Ann Neurol"},{"key":"358_CR88","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archneur.1976.00500090066014","volume":"33","author":"JL Trotter","year":"1976","unstructured":"Trotter JL, Hendin BA, Osterland CK. Cerebellar degeneration with Hodgkin disease. An immunological study. Arch Neurol. 1976;33:660\u20131.","journal-title":"Arch Neurol"},{"key":"358_CR89","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1212\/NXI.0000000000000068","volume":"2","author":"C Probst","year":"2015","unstructured":"Probst C, Komorowski L, de Graaff E, van Coevorden-Hameete M, Rogemond V, Honnorat J, et al. Standardized test for anti-Tr\/DNER in patients with paraneoplastic cerebellar degeneration. Neurol Neuroimmunol Neuroinflamm. 2015;2:e68.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"358_CR90","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clineuro.2005.01.008","volume":"108","author":"K Bruylant","year":"2006","unstructured":"Bruylant K, Crols R, Humbel RL, Appel B, De Deyn PP. Probably anti-Tr associated paraneoplastic cerebellar degeneration as initial presentation of a squamous cell carcinoma of the lung. Clin Neurol Neurosurg. 2006;108:415\u20137.","journal-title":"Clin Neurol Neurosurg"},{"key":"358_CR91","doi-asserted-by":"crossref","first-page":"25400","DOI":"10.1074\/jbc.M110793200","volume":"277","author":"M Eiraku","year":"2002","unstructured":"Eiraku M, Hirata Y, Takeshima H, Hirano T, Kengaku M. Delta\/notch-like epidermal growth factor (EGF)-related receptor, a novel EGF-like repeat-containing protein targeted to dendrites of developing and adult central nervous system neurons. J Biol Chem. 2002;277:25400\u20137.","journal-title":"J Biol Chem"},{"key":"358_CR92","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nn1492","volume":"8","author":"M Eiraku","year":"2005","unstructured":"Eiraku M, Tohgo A, Ono K, Kaneko M, Fujishima K, Hirano T, et al. DNER acts as a neuron-specific notch ligand during Bergmann glial development. Nat Neurosci. 2005;8:873\u201380.","journal-title":"Nat Neurosci"},{"key":"358_CR93","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.mcn.2005.10.003","volume":"31","author":"A Tohgo","year":"2006","unstructured":"Tohgo A, Eiraku M, Miyazaki T, Miura E, Kawaguchi SY, Nishi M, et al. Impaired cerebellar functions in mutant mice lacking DNER. Mol Cell Neurosci. 2006;31:326\u201333.","journal-title":"Mol Cell Neurosci"},{"key":"358_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004010050853","volume":"96","author":"F Graus","year":"1998","unstructured":"Graus F, Gultekin SH, Ferrer I, Reiriz J, Alberch J, Dalmau J. Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin\u2019s disease in the rat nervous system. Acta Neuropathol. 1998;96:1\u20137.","journal-title":"Acta Neuropathol"},{"key":"358_CR95","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/00001756-200205070-00035","volume":"13","author":"H Nishizumi","year":"2002","unstructured":"Nishizumi H, Komiyama T, Miyabayashi T, Sakano S, Sakano H. BET, a novel neuronal transmembrane protein with multiple EGF-like motifs. Neuroreport. 2002;13:909\u201315.","journal-title":"Neuroreport"},{"key":"358_CR96","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaneurol.2014.999","volume":"71","author":"M Greene","year":"2014","unstructured":"Greene M, Lai Y, Baella N, Dalmau J, Lancaster E. Antibodies to Delta\/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma. JAMA Neurol. 2014;71:1003\u20138.","journal-title":"JAMA Neurol"},{"key":"358_CR97","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0025-6196(12)62166-1","volume":"65","author":"JE Hammack","year":"1990","unstructured":"Hammack JE, Kimmel DW, O\u2019Neill BP, Lennon VA. Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies. Mayo Clin Proc. 1990;65:1423\u201331.","journal-title":"Mayo Clin Proc"},{"key":"358_CR98","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.12271","volume":"176","author":"S Jarius","year":"2014","unstructured":"Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol. 2014;176:149\u201364.","journal-title":"Clin Exp Immunol"},{"key":"358_CR99","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","volume":"6","author":"S Jarius","year":"2010","unstructured":"Jarius S, Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol. 2010;6:383\u201392.","journal-title":"Nat Rev Neurol"},{"key":"358_CR100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpneuro0764","volume":"4","author":"S Jarius","year":"2008","unstructured":"Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, et al. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol. 2008;4:202\u201314.","journal-title":"Nat Clin Pract Neurol"},{"key":"358_CR101","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1056\/NEJM197911293012205","volume":"301","author":"JF Desforges","year":"1979","unstructured":"Desforges JF, Rutherford CJ, Piro A. Hodgkin\u2019s disease. N Engl J Med. 1979;301:1212\u201322.","journal-title":"N Engl J Med"},{"key":"358_CR102","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM197310112891501","volume":"289","author":"RL Longmire","year":"1973","unstructured":"Longmire RL, McMillan R, Yelenosky R, Armstrong S, Lang JE, Craddock CG. In vitro splenic IgG synthesis in Hodgkin\u2019s disease. N Engl J Med. 1973;289:763\u20137.","journal-title":"N Engl J Med"},{"key":"358_CR103","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/1531-8249(199906)45:6<805::AID-ANA18>3.0.CO;2-G","volume":"45","author":"JE Greenlee","year":"1999","unstructured":"Greenlee JE, Dalmau J, Lyons T, Clawson S, Smith RH, Pirch HR. Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal. Ann Neurol. 1999;45:805\u20139.","journal-title":"Ann Neurol"},{"key":"358_CR104","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/archneur.1995.00540320098016","volume":"52","author":"E Stark","year":"1995","unstructured":"Stark E, Wurster U, Patzold U, Sailer M, Haas J. Immunological and clinical response to immunosuppressive treatment in paraneoplastic cerebellar degeneration. Arch Neurol. 1995;52:814\u20138.","journal-title":"Arch Neurol"},{"key":"358_CR105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s004150200006","volume":"249","author":"S Rauer","year":"2002","unstructured":"Rauer S, Czygan M, Kaiser R. Quantification of circulating anti-Hu antibody in serial samples from patients with paraneoplastic neurological syndromes: possible correlation of antibody concentration and course of neurological symptoms. J Neurol. 2002;249:285\u20139.","journal-title":"J Neurol"},{"key":"358_CR106","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1212\/WNL.0000000000000372","volume":"82","author":"B Balint","year":"2014","unstructured":"Balint B, Jarius S, Nagel S, Haberkorn U, Probst C, Blocker IM, et al. Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology. 2014;82:1521\u20138.","journal-title":"Neurology"},{"key":"358_CR107","doi-asserted-by":"crossref","unstructured":"Boronat A, Gelfand JM, Gresa-Arribas N, Jeong H-Y, Walsh M, Roberts K, et al. Encephalitis and antibodies to DPPX, a subunit of Kv4.2 potassium channels. AnnNeurol. 2012. In press (DOI: 10.1002\/ana.23756).","DOI":"10.1002\/ana.23756"},{"key":"358_CR108","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1212\/NXI.0000000000000086","volume":"2","author":"K Stoeck","year":"2015","unstructured":"Stoeck K, Carstens P, Jarius S, Raddatz D, St\u00f6cker W, Wildemann B, et al. Prednisolone and azathioprine are effective in DPPX antibody\u2013positive autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2015;2:e86.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"358_CR109","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/jnnp-2011-301506","volume":"83","author":"EB Becker","year":"2012","unstructured":"Becker EB, Zuliani L, Pettingill R, Lang B, Waters P, Dulneva A, et al. Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia. J Neurol Neurosurg Psychiatry. 2012;83:437\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"358_CR110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jns.2013.01.040","volume":"327","author":"B Balint","year":"2013","unstructured":"Balint B, Regula JU, Jarius S, Wildemann B. Caspr2 antibodies in limbic encephalitis with cerebellar ataxia, dyskinesias and myoclonus. J Neurol Sci. 2013;327:73\u20134.","journal-title":"J Neurol Sci"},{"key":"358_CR111","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/nan.12132","volume":"40","author":"C Steriade","year":"2014","unstructured":"Steriade C, Day GS, Lee L, Murray BJ, Fritzler MJ, Keith J. LGI1 autoantibodies associated with cerebellar degeneration. Neuropathol Appl Neurobiol. 2014;40:645\u20139.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"358_CR112","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bpa.12084","volume":"23","author":"S Jarius","year":"2013","unstructured":"Jarius S, Wildemann B. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol. 2013;23:661\u201383.","journal-title":"Brain Pathol"},{"key":"358_CR113","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation. 2012;9:14.","journal-title":"J Neuroinflammation"},{"key":"358_CR114","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ana.21450","volume":"64","author":"M Hadjivassiliou","year":"2008","unstructured":"Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol. 2008;64:332\u201343.","journal-title":"Ann Neurol"},{"key":"358_CR115","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/WNL.0000000000000970","volume":"83","author":"A McKeon","year":"2014","unstructured":"McKeon A, Lennon VA, Pittock SJ, Kryzer TJ, Murray J. The neurologic significance of celiac disease biomarkers. Neurology. 2014;83:1789\u201396.","journal-title":"Neurology"},{"key":"358_CR116","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2431-3-11","volume":"3","author":"MJ Fritzler","year":"2003","unstructured":"Fritzler MJ, Zhang M, Stinton LM, Rattner JB. Spectrum of centrosome autoantibodies in childhood varicella and post-varicella acute cerebellar ataxia. BMC Pediatr. 2003;3:11.","journal-title":"BMC Pediatr"},{"key":"358_CR117","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jnnp.57.5.638","volume":"57","author":"N Cimolai","year":"1994","unstructured":"Cimolai N, Mah D, Roland E. Anticentriolar autoantibodies in children with central nervous system manifestations of Mycoplasma pneumoniae infection. J Neurol Neurosurg Psychiatry. 1994;57:638\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"358_CR118","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1212\/01.wnl.0000178802.38268.1e","volume":"65","author":"A Uchibori","year":"2005","unstructured":"Uchibori A, Sakuta M, Kusunoki S, Chiba A. Autoantibodies in postinfectious acute cerebellar ataxia. Neurology. 2005;65:1114\u20136.","journal-title":"Neurology"},{"key":"358_CR119","first-page":"523","volume":"41","author":"H Ichikawa","year":"2001","unstructured":"Ichikawa H, Susuki K, Yuki N, Kawamura M. Ataxic form of Guillain-Barr\u00e9 syndrome associated with anti-GD1b IgG antibody. Rinsho Shinkeigaku. 2001;41:523\u20135.","journal-title":"Rinsho Shinkeigaku"},{"key":"358_CR120","first-page":"979","volume":"40","author":"T Araki","year":"2000","unstructured":"Araki T, Nakata H, Kusunoki S, Arai Y, Katayama Y. Immunoadsorption therapy with TR-350 (tryptophan column) for Guillain-Barr\u00e9 syndrome: investigation including serum antiganglioside antibody assay. Rinsho Shinkeigaku. 2000;40:979\u201385.","journal-title":"Rinsho Shinkeigaku"},{"key":"358_CR121","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1212\/01.wnl.0000317093.57106.33","volume":"71","author":"K Kaida","year":"2008","unstructured":"Kaida K, Kamakura K, Ogawa G, Ueda M, Motoyoshi K, Arita M, et al. GD1b-specific antibody induces ataxia in Guillain-Barr\u00e9 syndrome. Neurology. 2008;71:196\u2013201.","journal-title":"Neurology"},{"key":"358_CR122","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jnnp.2010.222836","volume":"82","author":"M Ito","year":"2011","unstructured":"Ito M, Matsuno K, Sakumoto Y, Hirata K, Yuki N. Ataxic Guillain-Barr\u00e9 syndrome and acute sensory ataxic neuropathy form a continuous spectrum. J Neurol Neurosurg Psychiatry. 2011;82:294\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"358_CR123","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.44.12.2412","volume":"44","author":"VA Lennon","year":"1994","unstructured":"Lennon VA. The case for a descriptive generic nomenclature: clarification of immunostaining criteria for PCA-1, ANNA-1, and ANNA-2 autoantibodies. Neurology. 1994;44:2412\u20135.","journal-title":"Neurology"},{"key":"358_CR124","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/01.wnl.0000256822.01222.bd","volume":"68","author":"S Jarius","year":"2007","unstructured":"Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology. 2007;68:1076\u20137.","journal-title":"Neurology"},{"key":"358_CR125","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00005072-198809000-00007","volume":"47","author":"JE Greenlee","year":"1988","unstructured":"Greenlee JE, Brashear HR, Herndon RM. Immunoperoxidase labelling of rat brain sections with sera from patients with paraneoplastic cerebellar degeneration and systemic neoplasia. J Neuropathol Exp Neurol. 1988;47:561\u201371.","journal-title":"J Neuropathol Exp Neurol"},{"key":"358_CR126","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ana.410180513","volume":"18","author":"KA Jaeckle","year":"1985","unstructured":"Jaeckle KA, Graus F, Houghton A, Cardon-Cardo C, Nielsen SL, Posner JB. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol. 1985;18:592\u2013600.","journal-title":"Ann Neurol"},{"key":"358_CR127","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ana.20238","volume":"56","author":"L Bataller","year":"2004","unstructured":"Bataller L, Sabater L, Saiz A, Serra C, Claramonte B, Graus F. Carbonic anhydrase-related protein VIII: autoantigen in paraneoplastic cerebellar degeneration. Ann Neurol. 2004;56:575\u20139.","journal-title":"Ann Neurol"},{"key":"358_CR128","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","volume":"291","author":"S Jarius","year":"2010","unstructured":"Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stoecker W, et al. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci. 2010;291:52\u20136.","journal-title":"J Neurol Sci"},{"key":"358_CR129","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-014-0206-3","volume":"11","author":"S Jarius","year":"2014","unstructured":"Jarius S, Scharf M, Begemann N, Stocker W, Probst C, Serysheva II, et al. Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia. J Neuroinflammation. 2014;11:206.","journal-title":"J Neuroinflammation"},{"key":"358_CR130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1742-2094-7-21","volume":"7","author":"S Jarius","year":"2010","unstructured":"Jarius S, Wandinger KP, Horn S, Heuer H, Wildemann B. A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization. J Neuroinflammation. 2010;7:21.","journal-title":"J Neuroinflammation"},{"key":"358_CR131","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/ard.2006.066027","volume":"66","author":"F Dubois-Galopin","year":"2007","unstructured":"Dubois-Galopin F, Beauvillain C, Dubois D, Pillet A, Renier G, Jeannin P, et al. New markers and an old phenomenon: prozone effect disturbing detection of filaggrin (keratin) autoantibodies. Ann Rheum Dis. 2007;66:1121\u20132.","journal-title":"Ann Rheum Dis"},{"key":"358_CR132","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jneuroim.2013.04.004","volume":"259","author":"S Mundiyanapurath","year":"2013","unstructured":"Mundiyanapurath S, Jarius S, Probst C, Stocker W, Wildemann B, Bosel J. GABA-B-receptor antibodies in paraneoplastic brainstem encephalitis. J Neuroimmunol. 2013;259:88\u201391.","journal-title":"J Neuroimmunol"},{"key":"358_CR133","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamaneurol.2013.574","volume":"70","author":"A McKeon","year":"2013","unstructured":"McKeon A, Martinez-Hernandez E, Lancaster E, Matsumoto JY, Harvey RJ, McEvoy KM, et al. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol. 2013;70:44\u201350.","journal-title":"JAMA Neurol"},{"key":"358_CR134","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archneurol.2010.209","volume":"67","author":"SJ Pittock","year":"2010","unstructured":"Pittock SJ, Parisi JE, McKeon A, Roemer SF, Lucchinetti CF, Tan KM, et al. Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Arch Neurol. 2010;67:1109\u201315.","journal-title":"Arch Neurol"},{"key":"358_CR135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","volume":"9","author":"M Reindl","year":"2013","unstructured":"Reindl M, Di Pauli F, Rostasy K, Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol. 2013;9:455\u201361.","journal-title":"Nat Rev Neurol"},{"key":"358_CR136","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1212\/WNL.37.11.1780","volume":"37","author":"RH Fabian","year":"1987","unstructured":"Fabian RH, Petroff G. Intraneuronal IgG in the central nervous system: uptake by retrograde axonal transport. Neurology. 1987;37:1780\u20134.","journal-title":"Neurology"},{"key":"358_CR137","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-510X(86)90150-4","volume":"73","author":"RH Fabian","year":"1986","unstructured":"Fabian RH, Ritchie TC. Intraneuronal IgG in the central nervous system. J Neurol Sci. 1986;73:257\u201367.","journal-title":"J Neurol Sci"},{"key":"358_CR138","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2013.05.003","volume":"261","author":"E Martin-Garcia","year":"2013","unstructured":"Martin-Garcia E, Mannara F, Gutierrez-Cuesta J, Sabater L, Dalmau J, Maldonado R, et al. Intrathecal injection of P\/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice. J Neuroimmunol. 2013;261:53\u20139.","journal-title":"J Neuroimmunol"},{"key":"358_CR139","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-5728(95)00063-8","volume":"60","author":"K Sakai","year":"1995","unstructured":"Sakai K, Gofuku M, Kitagawa Y, Ogasawara T, Hirose G. Induction of anti-Purkinje cell antibodies in vivo by immunizing with a recombinant 52-kDa paraneoplastic cerebellar degeneration-associated protein. J Neuroimmunol. 1995;60:135\u201341.","journal-title":"J Neuroimmunol"},{"key":"358_CR140","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nrm1150","volume":"4","author":"S Orrenius","year":"2003","unstructured":"Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol. 2003;4:552\u201365.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"358_CR141","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(05)66376-3","volume":"365","author":"C Sommer","year":"2005","unstructured":"Sommer C, Weishaupt A, Brinkhoff J, Biko L, Wessig C, Gold R, et al. Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet. 2005;365:1406\u201311.","journal-title":"Lancet"},{"key":"358_CR142","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/brain\/awq253","volume":"133","author":"C Geis","year":"2010","unstructured":"Geis C, Weishaupt A, Hallermann S, Grunewald B, Wessig C, Wultsch T, et al. Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain. 2010;133:3166\u201380.","journal-title":"Brain"},{"key":"358_CR143","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1093\/brain\/awq302","volume":"133","author":"A Vincent","year":"2010","unstructured":"Vincent A. Successful \u2018passive transfer\u2019 of paraneoplastic stiff person syndrome with antibodies to an intracellular antigen. Brain. 2010;133:3164\u20135.","journal-title":"Brain"},{"key":"358_CR144","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00702-012-0773-3","volume":"119","author":"C Geis","year":"2012","unstructured":"Geis C, Grunewald B, Weishaupt A, Wultsch T, Toyka KV, Reif A, et al. Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer. J Neural Transm. 2012;119:981\u20135.","journal-title":"J Neural Transm"},{"key":"358_CR145","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.cub.2008.10.044","volume":"18","author":"R Lundmark","year":"2008","unstructured":"Lundmark R, Doherty GJ, Howes MT, Cortese K, Vallis Y, Parton RG, et al. The GTPase-activating protein GRAF1 regulates the CLIC\/GEEC endocytic pathway. Curr Biol. 2008;18:1802\u20138.","journal-title":"Curr Biol"},{"key":"358_CR146","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0165-5728(02)00314-4","volume":"132","author":"S Shiraga","year":"2002","unstructured":"Shiraga S, Adamus G. Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J Neuroimmunol. 2002;132:72\u201382.","journal-title":"J Neuroimmunol"},{"key":"358_CR147","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.expneurol.2012.10.013","volume":"239","author":"N Hansen","year":"2013","unstructured":"Hansen N, Grunewald B, Weishaupt A, Colaco MN, Toyka KV, Sommer C, et al. Human stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats. Exp Neurol. 2013;239:202\u20139.","journal-title":"Exp Neurol"},{"key":"358_CR148","doi-asserted-by":"crossref","first-page":"e16775","DOI":"10.1371\/journal.pone.0016775","volume":"6","author":"C Geis","year":"2011","unstructured":"Geis C, Weishaupt A, Grunewald B, Wultsch T, Reif A, Gerlach M, et al. Human stiff-person syndrome IgG induces anxious behavior in rats. PLoS One. 2011;6:e16775.","journal-title":"PLoS One"},{"key":"358_CR149","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/1523-1747.ep12469994","volume":"100","author":"TD Golan","year":"1993","unstructured":"Golan TD, Gharavi AE, Elkon KB. Penetration of autoantibodies into living epithelial cells. J Invest Dermatol. 1993;100:316\u201322.","journal-title":"J Invest Dermatol"},{"key":"358_CR150","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.4049\/jimmunol.157.5.2082","volume":"157","author":"DJ Zack","year":"1996","unstructured":"Zack DJ, Stempniak M, Wong AL, Taylor C, Weisbart RH. Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody. J Immunol. 1996;157:2082\u20138.","journal-title":"J Immunol"},{"key":"358_CR151","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI119517","volume":"100","author":"K Yanase","year":"1997","unstructured":"Yanase K, Smith RM, Puccetti A, Jarett L, Madaio MP. Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1. J Clin Invest. 1997;100:25\u201331.","journal-title":"J Clin Invest"},{"key":"358_CR152","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1212\/WNL.38.7.1018","volume":"38","author":"NE Anderson","year":"1988","unstructured":"Anderson NE, Budde-Steffen C, Wiley RG, Thurman L, Rosenblum MK, Nadeau SE, et al. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration. Neurology. 1988;38:1018\u201326.","journal-title":"Neurology"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-015-0358-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T02:25:04Z","timestamp":1691979904000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jneuroinflammation.com\/content\/12\/1\/168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,17]]},"references-count":152,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["358"],"URL":"https:\/\/doi.org\/10.1186\/s12974-015-0358-9","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,17]]},"article-number":"168"}}